DEF 14C

INFORMATION STATEMENT

Company: Raphael Pharmaceutical Inc.
Filed: June 4, 2024
Period of Report: June 4, 2024
Accession Number: 0001213900-24-049686

View Document ↗ View on SEC.gov ↗